Covalon Technologies Ltd. announced that it will be showcasing IV Clear at the 2018 Scientific Meeting for the Association for Vascular Access (AVA or the Meeting). Covalon's IV ClearTM is indicated to cover and protect vascular access devices used in a wide variety of both acute and alternate care settings. Its patented combination of chlorhexidine and silver is proven to have a synergistic effect against some of the most commonly associated blood stream infection bacteriai and its skin-sparing silicone adhesive will not cause adhesive-related skin injury or pain during dressing changesii. Covalon will be at AVA, Booth 123, at the Columbus Convention Center in Columbus, Ohio from September 15th to 17th during all exhibit hours throughout the meeting.